Starting with our CCCare platform, used by clinicians during care, through the Mobile Co-Care app providing access to your data and information wherever and whenever you want it. With public reporting for quality and benchmarking via IBD-PERFECT, supported by our data environment to facilitate future focused research.
CCCure is working to make your IBD care portable, personalised, and connected - so you can take control wherever life takes you.
CCCure's data products - CCCare, IBD-PERFECT, and the Mobile Co-Care App - work with you to support optimal IBD care.
Our rich, continuously-updating, multi-source data environment is ready to provide detailed, real-world insights to guide your business in delivering the best for people with IBD.
Our rich, continuously-updating, multi-source data environment is ready to provide detailed, real-world insights for research into care and cure.
CCCure is an IBD-focused charity on a global mission: to improve the lives of people living with Inflammatory Bowel Disease through better care today — and the research that will create better treatments tomorrow.
We developed CCCare, the world’s first IBD-specific electronic medical record and patient management platform. By connecting patients, clinicians, and researchers, we’re creating a powerful, real-world evidence base that is already transforming care and accelerating innovation.
Our vision is simple yet ambitious — consistent, high-quality IBD care for every patient, everywhere. Our why? Because every data point, every conversation, and every innovation brings us one step closer to a cure.
Our mobile Co-Care app is coming soon and will connect patients and clinicians, providing the tools to monitor, manage, and improve IBD care in real time.
The continuously enlarging CCCure data environment gives researchers secure access to de-identified, real-world clinical data to power innovation in IBD treatment.
“Every piece of data adds to the story — about a patient’s journey, about the science of IBD, and about the care we deliver. When we connect these stories, we move closer to a future where every person with IBD gets the care they need, and every breakthrough happens faster.”